300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Blockchain
Gaming
Facebook
B2B
Social Network
Video Games
Medical Device
Big Data
Mobile
Automotive
Sports
Legal
Wellness
eSports
Construction
Education
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Venture Capital
Medical
Recruiting
Web3
Cannabis
LGBT
Fashion
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Social
Food and Beverage
Publishing
Beauty
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Infrastructure
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Nigeria
Russian Federation
Tajikistan
Guinea
Togo
Iran
Isle of Man
Nepal
Pakistan
Madagascar
Oman
Romania
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Canada
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United Kingdom
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Angola
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Europe
Cyprus
Mongolia
Qatar
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Oté Pharma, VC Fund

Oté Pharma

VC Fund

Oté Pharma is a reliable partner for high quality medical device products such as contact lens solutions, eye drops, nasal sprays.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Oté Pharma invests in

Health CareManufacturingInnovation Management

Stages Oté Pharma invests in

SeedFunding Round

Countries Oté Pharma invests in

United Kingdom

Investment Focus

Industry

  • Health Care 1 (50%)
  • Manufacturing 1 (50%)
  • Innovation Management 1 (50%)

Stage

  • Seed 1 (50%)
  • Funding Round 1 (50%)

Investments

CompanyDescriptionRoundLinks
Viopti Viopti
Viopti was established in May 2009 to bring to market a range of innovative premium branded products for the contact lens user. The companies lead product is the contactspod, a unique disposable contact lens case that is pre filled with solution and provides the end user with a hygienic option for storing their contact lenses.The company haslicensed the right to use the Polaroid brand across a range of products including eye drops and solutions. Polaroid is an iconic brand recognised and trusted globally.Viopti has been supported technically by IT partners Ote for solutions and regularity control and Wideblue for product development.Contactspod is the world's first, pre-filled, single use contact lens case. Hermetically sealed containing sterile multi-purpose solution, it is perfect when travelling and is ideal for spa's, beauty treatments & active sports.Contactspod is small, compact, convenient to carry around and easy to use. These are significant benefits for the traveller especially when flying, given today's baggage weight restrictions. $818K / Mar 30, 2012
Viopti Viopti
Viopti was established in May 2009 to bring to market a range of innovative premium branded products for the contact lens user. The companies lead product is the contactspod, a unique disposable contact lens case that is pre filled with solution and provides the end user with a hygienic option for storing their contact lenses.The company haslicensed the right to use the Polaroid brand across a range of products including eye drops and solutions. Polaroid is an iconic brand recognised and trusted globally.Viopti has been supported technically by IT partners Ote for solutions and regularity control and Wideblue for product development.Contactspod is the world's first, pre-filled, single use contact lens case. Hermetically sealed containing sterile multi-purpose solution, it is perfect when travelling and is ideal for spa's, beauty treatments & active sports.Contactspod is small, compact, convenient to carry around and easy to use. These are significant benefits for the traveller especially when flying, given today's baggage weight restrictions. $344K / Seed / Jul 04, 2011

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Blockchain
Gaming
Facebook
B2B
Social Network
Video Games
Medical Device
Big Data
Mobile
Automotive
Sports
Legal
Wellness
eSports
Construction
Education
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Venture Capital
Medical
Recruiting
Web3
Cannabis
LGBT
Fashion
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Social
Food and Beverage
Publishing
Beauty
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Infrastructure
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Nigeria
Russian Federation
Tajikistan
Guinea
Togo
Iran
Isle of Man
Nepal
Pakistan
Madagascar
Oman
Romania
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Canada
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United Kingdom
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Angola
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Europe
Cyprus
Mongolia
Qatar
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Oté Pharma invest in?

Oté Pharma invests primarily in Health Care, Manufacturing and Innovation Management startups, most often at Seed and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Oté Pharma last invest?

The most recent investment recorded for Oté Pharma closed in Mar 2012. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Oté Pharma Oté Pharma Find emails